Literature DB >> 15100631

Use of the SF-36 among persons with spinal cord injury.

Martin Forchheimer1, Mary McAweeney, Denise G Tate.   

Abstract

The purpose of this study was to explore the applicability of the SF-36 for assessing health-related quality of life among persons with spinal cord injuries. A sample of 215 persons who had experienced new, traumatic spinal cord injury and who had been discharged from their initial hospitalizations for at least 1 yr were included in the study. Correlations between the SF-36's physical and mental component scores appraised and the relationship of each component to level of neurologic impairment was assessed. As expected, the two components measured separate and distinct constructs; only physical component scores were associated with impairment severity.

Entities:  

Mesh:

Year:  2004        PMID: 15100631     DOI: 10.1097/01.phm.0000124441.78275.c9

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  39 in total

1.  Assessment of physical function and secondary complications after complete spinal cord injury.

Authors:  Shauna Dudley-Javoroski; Richard K Shields
Journal:  Disabil Rehabil       Date:  2006-01-30       Impact factor: 3.033

2.  Validity and reliability study of the Turkish version of Spinal Cord Independence Measure-III.

Authors:  H Unalan; T O Misirlioglu; B Erhan; M Akyuz; B Gunduz; E Irgi; H E Arslan; A Baltacı; S Aslan; D Palamar; A Kutlu; J Majlesi; U Akarırmak; S S Karamehmetoglu
Journal:  Spinal Cord       Date:  2015-02-10       Impact factor: 2.772

3.  Relationships among religiousness, spirituality, and health for individuals with stroke.

Authors:  Brick Johnstone; Kelly Lora Franklin; Dong Pil Yoon; Joseph Burris; Cheryl Shigaki
Journal:  J Clin Psychol Med Settings       Date:  2008-09-17

4.  Changes in pain and quality of life in depressed individuals with spinal cord injury: does type of pain matter?

Authors:  Elizabeth J Richardson; Larry G Brooks; J Scott Richards; Charles H Bombardier; Jason Barber; Denise Tate; Martin B Forchheimer; Jesse R Fann
Journal:  J Spinal Cord Med       Date:  2016-03-04       Impact factor: 1.985

5.  A validity study of the Spanish-World Health Organization Quality of Life short version instrument in persons with traumatic spinal cord injury.

Authors:  Sebastián Salvador-De La Barrera; Rubén Mora-Boga; Mª Elena Ferreiro-Velasco; Teresa Seoane-Pillado; Antonio Montoto-Marqués; Antonio Rodríguez-Sotillo; Sonia Pertega Díaz
Journal:  Spinal Cord       Date:  2018-05-23       Impact factor: 2.772

6.  The Neurogenic Bladder Symptom Score (NBSS): a secondary assessment of its validity, reliability among people with a spinal cord injury.

Authors:  Blayne Welk; Sara Lenherr; Sean Elliott; John Stoffel; Angela P Presson; Chong Zhang; Jeremy B Myers
Journal:  Spinal Cord       Date:  2017-11-29       Impact factor: 2.772

7.  Development and pilot test of the shriners pediatric instrument for neuromuscular scoliosis (SPNS): a quality of life questionnaire for children with spinal cord injuries.

Authors:  Louis Hunter; Fred Molitor; Ross S Chafetz; Mary Jane Mulcahey; Lawrence C Vogel; Randal R Betz; Craig M McDonald
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

8.  Review of cross-cultural issues related to quality of life after spinal cord injury.

Authors:  Denise Tate; Martin Forchheimer
Journal:  Top Spinal Cord Inj Rehabil       Date:  2014

Review 9.  Identifying and classifying quality-of-life tools for assessing pressure ulcers after spinal cord injury.

Authors:  Sander L Hitzig; Christina Balioussis; Ethne Nussbaum; Colleen F McGillivray; B Catharine Craven; Luc Noreau
Journal:  J Spinal Cord Med       Date:  2013-05-22       Impact factor: 1.985

10.  Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.

Authors:  Jamie M Zeitzer; Ban Ku; Doug Ota; B Jenny Kiratli
Journal:  J Spinal Cord Med       Date:  2013-10-24       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.